Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712543 · ClinicalTrials.gov registry record · Phase 4
A Preference Study Comparing Kristalose® and Liquid Lactulose
A Phase 4 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00712543: Completed Phase 4 study, sponsored by Cumberland Pharmaceuticals.
NCT00712543 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00712543, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
Interventions
- DRUG lactulose (Kristalose®)
- DRUG liquid lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
What the finished NCT00712543 record still lists
NCT00712543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which lactulose (Kristalose®) is the first listed.
NCT00712543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00712543 about?
NCT00712543 is a clinical study titled "A Preference Study Comparing Kristalose® and Liquid Lactulose". This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
What is the current status of trial NCT00712543?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2009-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00712543?
The interventions under investigation include: lactulose (Kristalose®) (DRUG), liquid lactulose (DRUG).
Who is sponsoring clinical trial NCT00712543?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00712543's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia